Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate

Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate

US Patent 10857102 · Granted Dec 8, 2020

Estimated economic value: $704,527,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations of AG102024
Combination formulation of two antiviral compounds2023
Combination formulation of two antiviral compounds2023
Formulations of AG102022
Combination formulation of two antiviral compounds2021
Combination formulation of two antiviral compounds2021
Combination formulation of two antiviral compounds2018
Combination formulation of two antiviral compounds2018
Use of solid carrier particles to improve the processability of a pharmaceutical2018
Combination formulation of two antiviral compounds2018
Combination formulation of two antiviral compounds2017
Combination formulation of two antiviral compounds2017